|
报告购买流程 |
定购方法
① 注册订购:
点击在线订购进行报告订购
我们的服务人员将在24小时内与您联系。
② 电话订购:
拔打电话:
北京:010-51266615 010-82863480/1/2/5
24小时:13436696826
传真:010-82863486
上海:021-64871266
021-64872612
24小时:13524982235
传真:021-64872324
签订协议
可从网上下载 报告订购表或由我们传真报告订购表或订购协议。
传真:010-82863486
付款方式
① 通过银行转帐的形式支付报告购买款项
② 我们收到款项后,24小时内快递报告或者发送报告邮件
③ 款项到帐后快递发票
银行电汇:
北京:
开户行:
上海浦东发展银行北京知春路支行
帐号:91170154740001300
户名: 北京佐思信息咨询有限责任公司
联系人:张小姐
|
|
 |
|
|
您的位置:佐思研究报告和竞争情报网>>研究报告交易平台>>医药产业>>生物制药业 |
|
|
动物保健产品抗菌药物市场研究报告——Animal Health Products Antibacterials Markets
|
|
字体【大 中
小】
|
|
纸介版价格:美元/篇
|
字数:万字
|
|
电子版价格:1999美元/篇
|
页数:70页 |
|
纸介版+电子版价格:美元
|
图表数:个
|
|
完成日期:2008-05-13
|
|
|
|
|
关键字: 抗菌药物|市场研究报告|Antibacterials |Markets |
联系方式:
北京:010-51266615 010-82863480/1/2/5 传真:010-82863486 上海:021-64871266 021-64872612 传真:021-64872324
[在线订购]
|
发布时间:2008年5月15日
摘要:
Veterinary antibacterials--antiseptics that only act against bacteria--comprise some of the most important pharmaceutical products on the animal health market. Yet despite a difficult regulatory environment--driven by concerns over the development of antibacterial resistance in consumers of livestock products--new products are still being launched. This has resulted in significant changes in the animal health products market. This study offers a detailed examination of the shape of the animal health products market globally over the next several years specific to antibacterials, analyzing both the livestock and companion animal markets.
正文目录:
Table of Contents:
|
- 1 Report Overview 4
- 1.1 Objectives of Report 4
- 1.2 Scope of Report 4
- 1.3 Methodology 4
- 1.4 Executive Summary 5
-
- 2 Animal Health Products Antibacterial Markets 6
- 2.1 Overview of Animal Health Products Market 6
- 2.1.1 World Products Market 7
- 2.1.2 U.S. Animal Health Products Market 8
- 2.1.3 European Animal Health Products Markets 9
- 2.1.4 Asian Animal Health Products Markets 10
- 2.2 Key Sector Highlights 11
- 2.3 Biologics Products Category 12
- 2.4 Companion Animal Health Products 12
-
- 3 Common Animal Diseases 13
- 3.1 Swine Fevers (African, Classical - Hog Cholera) 16
- 3.2 Yellow Fever 16
- 3.3 Anthrax 16
- 3.4 Crimean-Congo Hemorrhagic Fever 16
- 3.5 Foot and Mouth Disease (FMD) 17
- 3.6 Bovine Anaplasmosis 17
- 3.7 Bovine Babesiosis 18
- 3.8 Bovine Brucellosis 19
- 3.9 Bovine Genital Campylobacteriosis 19
- 3.10 Bovine Tuberculosis 19
- 3.11 Bovine Cysticercosis 19
- 3.12 Bovine Spongiform Encephalopathy 20
- 3.13 Dermatophilosis 21
- 3.14 Enzootic Bovine Leukosis 21
- 3.15 Hemorrhagic Septicemia 21
- 3.16 Infectious Bovine Rhinotracheitis / Infectious Pustular Vulvovaginitis 21
- 3.17 Theileriosis 22
- 3.18 Trichomonosis 22
- 3.19 Vesicular Stomatitis 22
- 3.20 Swine Vesicular Disease Picornaviridae Enterovirus 23
- 3.21 Rinderpest 23
- 3.22 Peste Des Petits Ruminants 23
- 3.23 Contagious Bovine Pleuropneumonia 23
- 3.24 Lumpy Skin Disease 24
- 3.25 Rift Valley Fever 24
- 3.26 Bluetongue Reoviridae Orbivirus 24
- 3.27 Ovine Epididymitis (Brucella Ovis) 25
- 3.28 Caprine and Ovine Brucellosis (Excluding B. Ovis) 25
- 3.29 Caprine Arthritis/Encephalitis 25
- 3.30 Contagious Agalactia 25
- 3.31 Contagious Caprine Pleuropneumonia 26
- 3.32 Enzootic Abortion of Ewes (Ovine Chlamydiosis) 26
- 3.33 Avian Chlamydiosis 26
- 3.34 Pullorum Disease 27
- 3.35 Myxomatosis 27
- 3.36 Tularemia 27
- 3.37 Contagious Equine Metritis 28
- 3.38 Dourine 28
- 3.39 Epizootic Lymphangitis 28
- 3.40 Porcine Brucellosis 28
- 3.41 Commercially-Significant Bacterial Infections in Farm Animals 29
-
- 4 Anti-bacterials Markets 31
- 4.1 Overview 31
- 4.2 Antibiotics Market Size 32
- 4.3 Global Sales of Animal Health Antibiotics by Region 32
- 4.3.1 U.S. Sales of Animal Health Antibiotics 32
- 4.3.2 European Sales of Animal Health Antibiotics 36
- 4.3.3 Japanese Sales of Animal Health Antibiotics 37
- 4.4 Animal Health Antibiotics Market Drivers 37
- 4.5 Growth Promotion in Livestock 38
-
- 5 Regulatory Overview of the Veterinary Health Market 42
- 5.1 Regulatory Environment 42
- 5.2 General Overview 42
- 5.3 Product Marketing Authority 43
- 5.4 Regulation of Animal Health Products in the European Union 43
- 5.5 Regulation of Animal Health Products in the U.S. 45
- 5.5.1 USDA 45
- 5.5.2 FDA 45
- 5.5.3 EPA 46
- 5.6 Regulation of Animal Health Products in Japan 46
- 5.6.1 Japanese Regulatory Environment 46
- 5.6.2 Withdrawal Periods 46
- 5.6.3 Japanese Filing Procedures for New Animal Drug Applications 46
- 5.6.4 Use of Outdated Animal Studies 46
- 5.6.5 Brand-Specific Listing for Antimicrobial, Antibiotic and Other Feed Additives 47
- 5.7 Proposed Regulation of Animal Antibiotics 47
- 5.8 Antibiotic Acquired Resistance and Animal Usage 47
-
- 6 Business Trends in the Industry 49
- 6.1 European Animal Health Industry 49
- 6.2 Trends Driving Demand 49
- 6.3 Antibiotic Usage 49
- 6.4 Mergers and Acquisitions 49
- 6.5 Bioterrorism and Food-borne PathogensWHO Guidelines 50
- 6.6 Animal Health Additive Growth Trends 50
-
- 7 Company Profiles 52
- 7.1 Abbott Laboratories 52
- 7.2 Agricultural Research Service 52
- 7.3 Alpharma, Inc. 53
- 7.4 BASF Agricultural Products and Nutrition 55
- 7.5 Bayer Animal Health 56
- 7.6 Boehringer Ingelheim Corp. 56
- 7.7 Elanco Animal Health 57
- 7.8 Fort Dodge Animal Health (Wyeth) 57
- 7.9 Heska Animal Health 58
- 7.10 Intervet International 60
- 7.11 IVAX Corporation 60
- 7.12 Merial Animal Health 60
- 7.13 Novartis Animal Health 61
- 7.14 Pfizer Animal Health 62
- 7.15 Roche Animal Nutrition and Health 65
- 7.16 Sanofi-Aventis 66
- 7.17 Schering-Plough Animal Health 67
- 7.18 Virbac S.A. 68
- 7.19 Wyeth (Fort Dodge Animal Health) 68
图表目录:
- INDEX OF FIGURES
-
- Figure 2.1: Worldwide Animal Health Products Market by Region, 2006 8
- Figure 2.2: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2006 9
- Figure 2.3: Worldwide Animal Health Products Market by Species, 2006 11
-
-
- INDEX OF TABLES
-
- Table 2.1: World Market for Animal Health Products, 2004-2012 7
- Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012 7
- Table 2.3: Worldwide Animal Health Products Market by Region, 2006 8
- Table 2.4: U.S. Animal Health Product Sales, 2004-2012 9
- Table 2.5: Japanese Animal Health Market, 2000-2012 10
- Table 2.6: Worldwide Animal Health Product Sales for Leading Producers, 2006 10
- Table 2.7: Dog and Cat Food Manufacturers 12
- Table 3.1: Diseases 13
- Table 3.2: Multiple Species Diseases 13
- Table 3.3: Cattle Diseases 14
- Table 3.4: Sheep and Goat Diseases 14
- Table 3.5: Equine Diseases 14
- Table 3.6: Swine Diseases 15
- Table 3.7: Avian Diseases 15
- Table 3.8: Fish Diseases 15
- Table 3.9: Other Veterinary Diseases 16
- Table 3.10: Use Categories for Anti-bacterials in Animal Health 29
- Table 3.11: Commercially-Significant Bacterial Infections in Pigs 29
- Table 3.12: Commercially-Significant Bacterial Infections in Poultry 30
- Table 3.13: Commercially-Significant Bacterial Infections in Cattle 30
- Table 4.1: Leading Antimicrobials by Type for Animal Health 31
- Table 4.2: Antibiotics Used in Animal Health by Family 32
- Table 4.3: Worldwide Sales of Animal Health Antibiotics, 2004-2012 32
- Table 4.4: U.S. Sales of Animal Health Antibiotics, 2004-2012 33
- Table 4.5: U.S. Volume of Animal Health Antibiotics Used, 1999-2006 33
- Table 4.6: Sales of Bayer's Baytril®, 2003-2009 34
- Table 4.7: Enrofloxacin (Quinolones) 34
- Table 4.8: Antibiotic Susceptibility for Common Swine Pathogens vs. Excenel® 35
- Table 4.9: U.S. Volume of Animal Health Antibiotics Used by Class Category, 2000-2005 35
- Table 4.10: European Sales of Animal Health Antibiotics, 2004-2012 36
- Table 4.11: European Veterinary Consumption of Therapeutic Antibiotics 36
- Table 4.12: Japanese Sales of Animal Health Antibiotics, 2004-2012 37
- Table 4.13: Animal Health Antibiotics Market Drivers 37
- Table 4.14: Commercial Animal Health Anti-bacterials by Class Type 40
- Table 4.15: Bacterial and Protozoal Threats to Poultry 41
- Table 4.16: Bacterial and Protozoal Threats to Pigs 41
- Table 7.1: Pfizer Animal Health Products 63
- Table 7.2: Pfizer Livestock Products 65
- Table 7.3: Pfizer Equine Products 65
- Table 7.4: Pfizer Companion Animal Products 65
|
|
如果这份报告还不能满足您的需求,或者您对这份报告还有什么意见或者建议,请您填写以下反馈信息。
|
|